Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.
Total femur prosthesis in oncological and not oncological series. Survival and failures / Muratori, Francesco; Mondanelli, Nicola; Prifti, Xhulio; Scoccianti, Guido; Roselli, Giuliana; Frenos, Filippo; Capanna, Rodolfo; Campanacci, Domenico Andrea. - In: JOURNAL OF ORTHOPAEDICS. - ISSN 0972-978X. - STAMPA. - 17:(2020), pp. 215-220. [10.1016/j.jor.2019.11.009]
Total femur prosthesis in oncological and not oncological series. Survival and failures
Mondanelli, Nicola;Prifti, Xhulio;Scoccianti, Guido;Roselli, Giuliana;Frenos, Filippo;Capanna, Rodolfo;Campanacci, Domenico Andrea
2020
Abstract
Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
